يعرض 1 - 10 نتائج من 20 نتيجة بحث عن '"mucosa inflammation"', وقت الاستعلام: 1.26s تنقيح النتائج
  1. 1
  2. 2

    المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı., Demirkaya, Metin, Özgür, Taner, Çelebi, Solmaz, Sevinir, Betül Berrin, Hacımustafaoğlu, Mustafa Kemal, AAG-8381-2021, AAH-1570-2021

    المصدر: Türk Pediatri Arşivi. 45:353-358

    وصف الملف: application/pdf

  3. 3

    المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961], Aravantinos, Gerasimos [0000-0002-2106-1713], Kalofonos, H. P. [0000-0002-3286-778X]

    المصدر: Annals of Oncology

    مصطلحات موضوعية: medicine.medical_treatment, Docetaxel, Skin disease, Gastroenterology, Carboplatin, Granulocyte colony-stimulating factor, Antineoplastic agents, Antineoplastic Combined Chemotherapy Protocols, Granulocyte Colony-Stimulating Factor, Prospective Studies, Treatment outcome, Drug safety, Etoposide, Ovarian Neoplasms, Multicenter study, Clinical trial, Oxaliplatin, Local, Oncology, Vertigo, Disease Progression, Taxoids, Infection, Human, Diarrhea, Neoplasm recurrence, medicine.medical_specialty, Bone marrow suppression, Paclitaxel, Clinical article, Febrile neutropenia, Antineoplastic Agents, Methylprednisolone, Article, Disease-Free Survival, Ovarian cancer, Humans, Platinum-resistant, Cancer recurrence, Aged, Disease progression, Drug infusion, Recombinant granulocyte colony stimulating factor, Follow up, Myalgia, Leukopenia, Monotherapy, medicine.disease, Cancer combination chemotherapy, Drug effect, Regimen, Drug resistance, Cisplatin, Ovarian neoplasms, Controlled clinical trial, Nausea and vomiting, Phytogenic, Middle aged, Fatigue, Priority journal, Platinum derivative, Anemia, Vinorelbine, Hematology, Middle Aged, Arthralgia, Ondansetron, Anorexia, Treatment Outcome, Drug choice, Female, medicine.symptom, medicine.drug, Adult, Abdominal pain, Neutropenia, Ovary cancer, Disease-free survival, Navelbine, Vinblastine, Mucosa inflammation, Antineoplastic combined chemotherapy protocols, Internal medicine, Neurotoxicity, medicine, Chemotherapy, Phase 2 clinical trial, Stomatitis, business.industry, Alopecia, Taxane derivative, Gemcitabine, Thrombocytopenia, Antineoplastic Agents, Phytogenic, Cancer survival, Surgery, Drug efficacy, Doxorubicin, Drug Resistance, Neoplasm, Neoplasm, Neoplasm Recurrence, Local, Antiemetic agent, Topotecan, business, Controlled study, Constipation, Prospective studies

  4. 4

    المصدر: Blood. 100:3141-3146

    مصطلحات موضوعية: Male, leukocyte count, vomiting, medicine.medical_treatment, diarrhea, heart failure, idarubicin, Biochemistry, Gastroenterology, Hepatitis, law.invention, Leukemia, Promyelocytic, Acute, Randomized controlled trial, cytarabine, Antibiotics, law, cancer diagnosis, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Medicine, promyelocytic leukemia, cancer survival, Child, Promyelocytic, Antibiotics, Antineoplastic, Leukemia, adult, Remission Induction, article, Age Factors, clinical trial, Hematology, Middle Aged, Antineoplastic, Chemotherapy regimen, female, multivariate analysis, Treatment Outcome, priority journal, cancer regression, monotherapy, drug induced disease, mucosa inflammation, Chemical and Drug Induced Liver Injury, Infection, mercaptopurine, methotrexate, tioguanine, bleeding, cancer combination chemotherapy, controlled clinical trial, controlled study, drug infusion, follow up, human, infection, kidney failure, liver failure, major clinical study, male, multicenter study, randomized controlled trial, survival time, 6-Mercaptopurine, Adolescent, Adult, Cytarabine, Disease-Free Survival, Female, Follow-Up Studies, Hemorrhage, Hepatitis, Toxic, Humans, Idarubicin, Leukocyte Count, Methotrexate, Vomiting, medicine.drug, Acute promyelocytic leukemia, medicine.medical_specialty, Anthracycline, Immunology, Acute, Infections, Internal medicine, Chemotherapy, business.industry, Cell Biology, Toxic, medicine.disease, Surgery, business, Settore MED/15 - Malattie del Sangue

  5. 5

    المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961]

    المصدر: BMC Cancer

    مصطلحات موضوعية: Oncology, Survival rate, Neurologic disease, Docetaxel, Skin disease, Multiple cycle treatment, Eye disease, Breast cancer, Phase 3 clinical trial, Antineoplastic agents, Antineoplastic Combined Chemotherapy Protocols, Pathology, Drug fatality, Anthracyclines, Disease free survival, Open study, Fulvestrant, Mastectomy, Dose-dense sequential chemotherapy, Multicenter study, Clinical trial, Antineoplastic agent, Randomized controlled trial, Granulocyte colony stimulating factor, Goserelin, Thrombocyte, Infection, Human, Diarrhea, medicine.medical_specialty, Paclitaxel, Vomiting, Febrile neutropenia, Heart failure, Antineoplastic Agents, Major clinical study, Side effect, Heart disease, Anastrozole, Vascular disease, Article, Disease-Free Survival, Drug Administration Schedule, Epidermal growth factor receptor 2, Taxanes, Median follow-up, Genetics, Humans, Hemoglobin, Phase 3 clinical trial (topic), Cyclophosphamide, Aged, Follow up, Leukopenia, Myalgia, medicine.disease, Metabolic disorder, Cancer combination chemotherapy, Regimen, Tamoxifen, Methotrexate, Cancer adjuvant therapy, Asymptomatic disease, Comparative study, Breast neoplasms, Cancer Research, Partial mastectomy, Heart ejection fraction, Gonadorelin, Skin manifestation, Monoclonal, Edema, Overall survival, Middle aged, Humanized, Fatigue, Adjuvant, Drug withdrawal, Neutrophil, Nausea, Middle Aged, Gastrointestinal disease, Arthralgia, Anorexia, Chemotherapy, Adjuvant, Cancer radiotherapy, Female, Fluorouracil, Epirubicin, medicine.drug, Research Article, Monoclonal antibody, Adult, Neutropenia, Disease-free survival, Pain, Breast Neoplasms, Follow-up studies, Antibodies, Monoclonal, Humanized, Antibodies, Young Adult, Mucosa inflammation, Internal medicine, Antineoplastic combined chemotherapy protocols, medicine, Chemotherapy, Early cancer, Taxane, business.industry, Drug administration, Loading drug dose, Lymphocytopenia, Drug administration schedule, Allergic reaction, Patient compliance, Aromatase inhibitor, Leukocyte, Trastuzumab, Adjuvant chemotherapy, Drug efficacy, Young adult, Lung disease, business, Controlled study, Follow-Up Studies

  6. 6
    دورية أكاديمية
  7. 7

    المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Patoloji Anabilim Dalı., Kılıç, Sara Şebnem, Kavurt, Sumru, Adım, Şaduman Balaban, AAH-1658-2021

  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية